Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02804334 · ClinicalTrials.gov registry record
The Role of Molecules in Blood Cells for Diagnosing Bipolar Disorders
A clinical trial, sponsored by University Hospitals Cleveland Medical Center.
- Terminated
- Registry status
- 29
- Enrollment target
NCT02804334 is a clinical trial that was terminated before completion, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 29 participants.
The verdict
NCT02804334 was terminated before completion, sponsored by University Hospitals Cleveland Medical Center.
- TERMINATED
- Registry status
- 29 participants
- Enrollment target
Study Summary
The goal of this project is to study \~45 molecules in blood cells that may differentiate patients with bipolar disorder from healthy controls.
Interventions
- PROCEDURE Blood draw
- PROCEDURE Psychiatric Questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2016-06 |
| Est. Completion | 2018-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02804334
The ClinicalTrials.gov registry entry for NCT02804334 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Blood draw is the first listed.
NCT02804334 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02804334 about?
NCT02804334 is a clinical study titled "The Role of Molecules in Blood Cells for Diagnosing Bipolar Disorders". The goal of this project is to study \~45 molecules in blood cells that may differentiate patients with bipolar disorder from healthy controls.
What is the current status of trial NCT02804334?
This trial is currently terminated. The enrollment target is 29 participants. The study started on 2016-06. Estimated completion is 2018-10.
What interventions are being tested in trial NCT02804334?
The interventions under investigation include: Blood draw (PROCEDURE), Psychiatric Questionnaires (PROCEDURE).
Who is sponsoring clinical trial NCT02804334?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.